EyeCBetter registers trial testing non-contact eye pressure device against gold standard tonometer
A single-center study of EyeCBetter's investigational Photobionic IOP Biomonitor was registered, comparing it to Goldmann applanation tonometry in glaucoma monitoring.
EyeCBetter Corporation has one clinical trial record on file this cycle, registered with a collaborator from the National Eye Institute.
- The trial, listed under NCT07762053 with acronym PIB, is a prospective, non-randomized, single-center study evaluating the safety and performance of EyeCBetter's investigational "Photobionic IOP Biomonitor Tonometer." The record's status is active not recruiting1, with an actual start date of 2026-08-31 and first posted 2026-08-13. The device is described as using a very low-power, eye-safe infrared light and a gentle sound signal to detect tiny movements on the white part of the eye, with a camera recording these movements and a computer analyzing the information to estimate eye pressure.1 The study's primary objective is to evaluate IOP repeatability as measured by PIB in a side-by-side comparison of PIB and GAT.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.